Sorghum phenolic compounds associate with cell apoptosis in human hepatocarcinoma HepG2 and colorectal adenocarcinoma Caco2 cells by Shen, Jiamin
  
  
Sorghum phenolic compounds associate with cell apoptosis in human hepatocarcinoma HepG2 



























Department of Food, Nutrition, Dietetics and Health 











 Approved by: 
 
Major Professor  










Sorghum is a rich source of various phytochemical phenolics including phenolic acids, 
anthocyanins, and flavonoids, etc. These phenolics have been associated with chronic disease 
prevention, especially cancer. However, the available data for various varieties of sorghum on 
cancer are limited. In this study, two different sorghum accessions were selected and the 
extracted phenolics were tested for their impact on cell growth and apoptosis in both 
hepatocarcinoma HepG2 and colorectal adenocarcinoma Caco-2 cell lines. Total phenolic 
contents determined by Folin-Ciocalteu were 2.11 mg GAE/g DW in F10000 and 21.89 mg 
GAE/g DW in PI329694, respectively. Cells treated with various concentrations of the extracted 
phenolics at 0-200 M GAE up to 72 hrs resulted a dose dependent reduction of cell number. 
The apoptosis as measured by the FITC Annexin V protocol was also resulted a significant 
increase in the extract of PI329694 when comparing with the extract of F10000. Overall, these 
results showed a positive evidence that a direct impact of the sorghum phenolics on either 
HepG2 or Caco-2 cellular growth inhibition and apoptosis induction. Both anti-growth and 
apoptotic induction seemed associated with their phenolic contents. Therefore, this study 
suggests that sorghum prevent against cancer through phenolic-mediated cancer cell inhibition 
and apoptosis induction. 
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Chapter 1 - Literature review 
 1.1 Sorghum background  
As an important crop worldwide, sorghum was ranked as the fifth most valuable crop 
after wheat, rice, maize, and barley. The United States is the largest producer and exporter of 
sorghum, accounting for 17% of the world’s production and almost 77% of the world’s sorghum 
exports over the past 5 years. Even sorghum is not considered as a traditional food in United 
States, it is one of the most important staple foods in the impoverished regions of the world. For 
millions of poor rural people in the semiarid tropics of Asia and Africa, sorghum remains a 
principal source of energy, protein, vitamins, and minerals. However, because sorghum has poor 
sensory quality and low digestibility, it is mainly used as a livestock ingredient and biofuel 
source in developed countries [1]. Stefoska-Needham et al. (2015)[2] claimed that people 
underestimate the value of sorghum because it is often used as animal feed. In recent years, 
sorghum has drawn the attention of scientists because its natural “gluten-free” characteristic 
proved beneficial to people with celiac disease [3]. Sorghum as a valuable, inexpensive, and 
nutritional crop that may have higher bioactive phenolic contents than major cereals such as 
wheat, barley, rice, maize, rye, and oats [2]. Research has shown that sorghum is rich in various 
nutrients, including proteins, vitamins, fiber, and minerals. In addition, sorghum is high in 
phytochemicals such as tannins, phenolic acids, anthocyanins, phytosterols, and policosanols [4]. 
These phytochemicals from the biosynthesis of secondary metabolites that provide potential 
health benefits such as antioxidant activity, cholesterol-lowering properties, and anticarcinogenic 
properties, which can lead sorghum to be a functional food or ingredient additives [5]. Interest in 
the long-term use of food-derived products for the prevention of cancer in different populations 
has been increasing because they are expected to be safe and are not perceived as “medicine” [6], 
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[7]. Schwedhelm et al. (2016)[8] reported that healthy and high-quality diets can reduce the 
damage cause by the free radicals and promote health benefit human such as decrease the cancer 
mortality. 
 1.2 Phenolic compounds in sorghum 
Phenolic compounds comprise one (phenolic acids) or more (polyphenols) aromatic rings 
with attached hydroxyl groups in their structures. They are broadly distributed in the plant 
kingdom and are the most abundant secondary metabolites of plants [3], [4], [9]–[12]. There are 
more than 8,000 phenolic structures currently known, ranging from simple molecules such as 
phenolic acids to highly polymerized substances such as tannins [11], [13]–[15]. Simple phenols 
are compounds with at least one hydroxyl group attached to an aromatic ring [11]. For example, 
catechol, resorcinol, and phloroglucinol are classified as simple phenols [11]. Simple phenols are 
uncommon plant constituents, but Towo, Svanberg, and Ndossi [13] reported catechol and 
resorcinol in sorghum grains. Phenolic acids and their derivatives are significant phenolic 
compounds abundantly occurring in sorghum grains, mainly as benzoic and cinnamic acid 
derivatives [4], [14]. Phenolic acid is likely to be esterified into cell wall polymers and stay in 
bound form, whereas ferulic acid is the most abundant bound phenolic acid in sorghum [16]. 
Phenolic acids show good antioxidant activity that may contribute to the potential health benefit 
from consuming sorghum. Polyphenols are phytochemicals belonging to a vast group of plant-
derived compounds involving many phenol structural units [12]. They can be classified into two 
main groups, non-flavonoids and flavonoids, according to the functions of the aromatic groups 
containing phenol and the aliphatic carbon skeleton that binds these rings to one another [12]. 
The main classes of polyphenol includes phenolic acids, flavonoids, stilbenes, and lignans [17]. 
Flavonoids are the most abundant polyphenol compounds in plants based on the chemical 
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structure of a C6-C3-C6 skeleton [12]. More than 4000 flavonoids have been discovered, and 
these can be divided into six subclasses, namely flavanols, flavones, flavanones, flavanols, 
anthocyanins, and isoflavones, according to their distinct heterocycle aromatic rings [1]–[5], 
[10], [11], [14], [15], [17]–[26][22]. The color of sorghum reflects its flavonoid content. 
Sorghum with a black pericarp contains higher levels of flavan-4-ols and anthocyanins than other 
varieties [27]. 
 1.3 Extraction solvent and phenolic compounds 
Phytochemicals such as phenolic compounds are mainly extracted using organic solvent 
or aqueous and organic solvents. Liu et al. (2009) [28]reported that acetone has a potent 
capability to extract polyphenols from lychee flowers compared with methanol, water, and 
ethanol. IIoki-Assanga et al. (2015) [29]suggested that aqueous methanol can be used as a 
solvent for extracting polyphenols from Phoradendron californicum oak. More recently, 
Metrouh-Amir et al. (2015) [30]suggested that aqueous and organic solvents are more efficient 
than absolute organic solvents in extracting polyphenols. No best extraction solvent has been 
proposed for phenolic compounds, but solvents with higher polarity are likely to be used owing 
to the solubility of their polyphenols. 
 1.4 Phenolic compounds in sorghum that are associated with cancer prevention 
Phenolic compounds are biosynthesized naturally and derived from the secondary 
metabolites of plants, which have antioxidant, cytotoxic, and antimicrobial bioactivities, among 
others[4], [10], [12], [31], [32]. Among cereals, sorghum has the highest content of phenolic 
compounds. In some specialty sorghum varieties, the sorghum phenolic content can reach up to 
6%[2], [4]. High levels of phenolic compounds enhance bioactive properties such as antioxidant 
activity. Awkia et al. (2009) [8]suggested that the anticancer activity of sorghum may be 
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attributed to its potent antioxidant activity and phase II enzymes. The phenolic compounds found 
in tea and wine, which are phenol-rich products, have been reported to have anticancer effects 
[24], [33]–[35]. Reference data from epidemiological and animal studies have shown that 
phenolic compounds could have potential health benefits such as cancer prevention that are 
attributable to their biological properties, including antioxidant activity, cell growth inhibition, 
and induction of cell apoptosis [8], [36]–[39]. Schwedhelm et al. (2016) reported that healthy 
and high-quality diets are inversely associated with human cancer mortality. Seong-Ho et al. 
(2020) [40]suggested that a novel high-phenol sorghum bran exhibited mechanisms of anticancer 
activity. 
 1.5 Causes of cancer 
Cancer, the second leading cause of death worldwide after cardiovascular diseases, is a 
disease in which some cells in the body grow uncontrollably and spread into other parts of the 
body[41], [42]. Tumor development relies on the disruption of the extracellular matrix around a 
cell and begin when DNA in a cell or population of cells is damaged by exposure to 
carcinogen[43], [44]. The three major cancer-inducing factors are cigarette smoking, infection or 
inflammation, and nutrition or diet[45]. 
Cancer development is a multistage process that involves a series of individual steps, 
including initiation, promotion, progression, invasion, and metastasis. Genetic mutation occurs 
when the DNA damage escapes repair, which leads to somatic mutation in the damaged cells. 
The resulting mutated cells can reproduce and form into cloned mutated cells through 
mitosis[43]. Tumor promotion is a selective process of proliferation and expansion of mutated 
cells into a larger premalignant tumor cell population, which can be inhibited if diagnosed and 
intervened in the precancerous stage. During progression, precancerous cells develop into tumors 
5 
through clonal expansion. This can further induce tumor invasion and metastasis, which are 
corresponding processes that stimulate tumor cells to detach from the primary tumor mass and 
migrate into surrounding tissues toward blood or lymphatic vessels, thereby forming a secondary 
lesion. Tumor invasion and metastasis are major causes of cancer mortality. Cancer is 
characterized as the accumulation and alteration of precancerous cells through initiation, 
promotion, and progression. Therefore, the approach to cancer prevention is to regulate and alter 
the mechanism of the cell mutation or tumor in the early stage. 
 1.7 Phenolic compounds vitro study and cell cycle/apoptosis 
In cancer development, disruption of the normal regulation of cell-cycle progression and 
division is an important event. The cell cycle involves a recurring sequence of events that 
includes the duplication of cell contents and subsequent cell division. For eukaryotic cells, cell 
cycle is defined as the interval between the completion of the mitosis of a cell and the 
completion of the mitosis of one or both of its daughter cells. Traditionally, the cell cycle of 
eukaryotic cells is divided into four phases as follows: Gap phase 1 (G1), DNA synthesis (S), 
Gap phase 2 (G2), and mitosis (M). Gap phase 2 is the preparation stage for cell division. The 
mitotic phase involves the separation of chromosomes after cell division. The progression of the 
cell cycle from one phase to the next involves a sequence of events that are regulated by the 
activation and inactivation of checkpoints in the mitotic phase, during which the status of the cell 
and environmental cues can be monitored and evaluated. The G1 checkpoint regulates the cell 
size, nutrients, and molecular signals, that is, the growth factors, and DNA damage. The G2 
checkpoint regulates DNA damage and replication. Finally, the M checkpoint, or spindle 
checkpoint, regulates the chromosome attachment to the spindle at the metaphase plate. 
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Apoptosis, or programmed cell death, is an important mechanism in normal cell 
development and is regulated by various oncogenes[46]–[48]. The programmed cell death allows 
the cells to self-destruct when stimulated by the tagger. This occurs mainly via extrinsic (death 
receptor) and intrinsic (mitochondria) pathways that involve condensation of the nucleus and 
cytoplasm after cellular partitioning into fragments for disposal. Normally, human cells grow and 
multiply to form new cells as the body needs them. When cells grow old or become damaged, 
they die and are replaced by new cells. However, cancer cells escape the checkpoints in the cell 
cycle and grow permanently. 
Studies performed in vitro have demonstrated that phenolic components can prevent 
and/or inhibit the development of different types of cancer by regulating cell signal transduction 
and gene expression. Seong-Ho et al. (2020) [49]found that a novel high-phenol sorghum bran 
from Puerto Vallarta, Mexico, has the potential to induce apoptosis and suppress the cell growth 
of human colon cancer cells. Other recent vitro studies correlated sorghum extract treatment with 
the development of cancer cells, including breast (MCF-7) [50], colon (HT-15) [49], and liver 
cancer cells (HepG2) [51]. The results showed that treatment with sorghum phenolic extracts 
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Chapter 2 - Experiments 
 2.1 Abstract 
Sorghum is a rich source of various phytochemical phenolics including phenolic acids, 
anthocyanins, and flavonoids, etc. These phenolics have been associated with chronic disease 
prevention, especially cancer. However, the available data for various varieties of sorghum on 
cancer are limited. In this study, two different sorghum accessions were selected and the 
extracted phenolics were tested for their impact on cell growth and apoptosis in both 
hepatocarcinoma HepG2 and colorectal adenocarcinoma Caco-2 cell lines. Total phenolic 
contents determined by Folin-Ciocalteu were 2.11 mg GAE/g DW in F10000 and 21.89 mg 
GAE/g DW in PI329694, respectively. Cells treated with various concentrations of the extracted 
phenolics at 0-200 M GAE up to 72 hrs resulted a dose dependent reduction of cell number. 
The apoptosis as measured by the FITC Annexin V protocol was also resulted a significant 
increase in the extract of PI329694 when comparing with the extract of F10000. Overall, these 
results showed a positive evidence that a direct impact of the sorghum phenolics on either 
HepG2 or Caco-2 cellular growth inhibition and apoptosis induction. Both anti-growth and 
apoptotic induction seemed associated with their phenolic contents. Therefore, this study 
suggests that sorghum prevent against cancer through phenolic-mediated cancer cell inhibition 
and apoptosis induction. 
 





 2.2 Introduction 
Sorghum, one of the cereal crops consumed worldwide, was ranked as the fifth most 
valuable crop after wheat, rice, maize, and barley [1]. The United States is the largest producer 
and exporter of sorghum, accounting for 17% of the world's production and almost 77% of the 
world's sorghum exports over the past 5 years (USDA-ARS). Numerous people in developing 
countries use sorghum as a food source. However, in developed countries, sorghum is not 
consider as a traditional food and mostly used as a livestock ingredient and in biofuel production 
[2]. Stefoska-Needham et al. (2015) [3]claimed that people underestimate the value of sorghum 
because it is often used as animal feed. In recent years, sorghum has drawn the attention of 
scientists because its natural “gluten-free” characteristic proved beneficial to people with celiac 
disease [4]. Sorghum as a valuable, inexpensive, and nutritional crop that may have higher 
bioactive phenolic contents than major cereals such as wheat, barley, rice, maize, rye, and oats 
[3]. The present of phenolic compounds in sorghum are naturally synthesis by the secondary 
metabolites of plants, which arise the interested as a functional food or ingredients, especially for 
cancer prevention[1], [5]–[8]. Interest in the long-term use of food-derived products for the 
prevention of cancer in different populations has been increasing because they are expected to be 
safe and are not perceived as “medicine”[9], [10]. Schwedhelm et al. (2016) [11]reported that 
healthy and high-quality diets are inversely associated with human cancer mortality.  
 Reference data from epidemiological and animal studies have shown that phenolic 
compounds could have potential health benefits such as cancer prevention owing to their 
biological properties, including antioxidant activity, cell growth inhibition, and induction of cell 
apoptosis [12]–[16][17], [18] . Studies found that the phenolic compounds in tea and wine, 
which are phenol-rich products, have anticancer effects [19]–[22]. More recently, Seong-Ho et 
19 
al. (2020) [23]found that a novel high-phenol sorghum bran from Puerto Vallarta, Mexico, has 
the potential to induce apoptosis and suppress the cell growth of human colon cancer cells. Other 
in vitro studies published recently have correlated sorghum extract administration with the 
development of cancer cells, including breast (MCF-7) [8], colon (HT-15) [23], and liver cancer 
cells (HepG2) [23]. The results showed that administration of sorghum phenolic extracts 
consistently induced cell apoptosis and suppressed cell growth. Many studies have shown that 
cancer prevention correlates with the consumption of fruits and vegetables containing phenolic 
compounds, but sorghum phenolic compounds as a new arises topic have lag data compare 
phenolic rich product such as wine and tea[17], [18], [20], [22], [24]–[28]. Therefore, 
demonstrated more studies on sorghum phenolic compounds in vitro and in vivo are important.  
In the present study, human hepatocellular carcinoma HepG2 and colon adenocarcinoma 
Caco-2 cells were selected because the major site for metabolism and absorption including 
phenolic compounds. Two sorghum accessions with different phenolic contents were selected to 
examine cell growth and apoptosis throughout the course of the cell treatments. The aim of this 
study was to investigate the cell inhibition and apoptosis induction effects of sorghum phenolic 
extracts on cancer cells and correct the apoptosis result presented in previous study. 
 2.3 Experimental Section 
 2.3.1. Sorghum accessions 
Sorghum accession P1329694 was selected because of its high phenolic contents. Sorghum 
accession F10000 was selected as a control because of it lower phenolic content. Sorghum 
samples were collected by the United States Department of Agriculture-Agricultural Research 
Service (USDA-ARS) Grain Quality and Structure Research Unit (1515 College Avenue, 
Manhattan, KS, USA). 
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 2.3.2. Standards and reagents 
Acetone, ethanol, Folin-Ciocalteu reagent, gallic acid, sodium carbonate, and Dulbecco’s 
phosphate-buffered saline (DPBS) were purchased from Sigma-Aldrich (St. Louis, MO). Cell 
treatment reagents such as Dulbecco’s modified eagle medium (DMEM), fetal bovine serum 
(FBS), and trypsin-EDTA were purchased from Fisher Scientific Co. L.L.C (Pittsburgh, PA, 
USA). Reagents for cell apoptosis such as the FITC Annexin V apoptosis detection kit, 
propidium iodide (PI), annexin-binding buffer, and cell-staining buffer were purchased from 
BioLegend (San Diego, CA, USA). 
 2.3.3 Extraction 
Sorghum flour (5 g) was mixed with 50 mL of 70% aqueous acetone (v/v) and shaken using a 
211DS shaking incubator (Labnet International Inc., NJ, USA) for 2 h. The samples were then 
stored at −20°C in the dark overnight to allow the phenolic compounds to completely diffuse into 
the solvent. On the next day, the extracts were centrifuged at 2970×g for 10 min. The residue 
was rinsed with an additional 50 mL of solvent with 5 min of shaking and centrifuged at 2970×g 
for 10 min. A combination of two aliquots was used for determination of the total phenolic 
content (TPC) and cell treatment. The extracts for cell treatment were dried under a stream of 
nitrogen followed by evaporation. After all the water had evaporated, the extracts were freeze-
dried to obtain a completely dry powder. The dry extracts were then dissolved in 
dimethylsulfoxide (DMSO) to make stock solutions and stored at −20°C for further analysis. The 
stock solution was diluted with fresh medium to achieve the desired concentrations (0–200 μM 
gallic acid equivalents [GAE]) before each treatment. The final DMSO concentration in each 
treatment was kept within ≤0.1% to prevent an altered cell growth compared with the vehicle-
free medium. All extractions and treatments were performed in triplicate. 
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 2.3.4 Total phenolic content 
The TPC of the sorghum extract was evaluated using the Folin-Ciocalteu method (Thamnarathip 
et al., 2016). Briefly, 0.1 mL of extract sample was diluted in 7.9 mL of water and then mixed 
with 0.5 Folin-Ciocalteu reagent. Then, 1.5 mL of 20% sodium carbonate solution was added, 
and the mixture was then reacted for 2 h. The samples were read absorbance at 760 nm by a 
microplate reader (SynergyHT, Biotek) with the Gen5 TM2.0 data analysis software (Winnoski, 
USA). Gallic acid (0–0.06 mg/mL) was used as the standard, and the TPC was calculated as mg 
GAE/g of dry weight (DW). 
 2.3.5 Cell culture 
Human hepatocellular carcinoma HepG2 cells were provided by the Grain Science Department, 
Kansas State University (Manhattan, KS 66506). Human colorectal adenocarcinoma Caco-2 cells 
were provided by the USDA-ARS Grain Quality and Structure Research Unit (1515 College 
Avenue, Manhattan, KS 66502, USA). The complete medium was made by mixing DMEM with 
10% FBS and 1% penicillin/streptomycin. Then, the cells were cultured in the supplemented 
medium at 37°C in a 5% CO2 humidified atmosphere. The exponential growth phase of the cells 
was used for all the experiments. 
 2.3.6 Cell growth 
The initial 2-mL cell suspension (1 × 105 cells/mL) were seeded into 6-well plates and cultured 
in a humidified incubator overnight to allow adhesion. The sorghum extracts at different 
concentrations (0–200 M) in DMEM were prepared ahead and then used to exchange the original 
DMEM in the 6-well plates to begin the treatment. Cells were incubated at 37°C for 72 h. All the 
cells were grown three times separately to minimize the deviation. 
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 2.3.7 Cell concentration and viability 
The medium in the 6-well plates was first removed, and DPBS was used next for cell rinsing. 
The trypsin-EDTA solution (0.05%) at 37°C was used to detach the cells. Then, all the mixtures 
were collected into a 15-mL tube and centrifuged at 200×g for 5 min. The supernatant was 
removed, and 0.5 mL of medium was added to resuspend the cells. Twenty microliters of 
resuspended cells was collected in a small vial and mixed with 20 µL of acridine orange and 
propidium iodide. Twenty microliters of the mixture sample was added into a counting chamber 
and then inserted in a Nexcelom Auto 2000 cellometer (Nexcelom Bioscience LLC., 
Manchester, UK). Cell concentration and viability were tested using the cellometer through the 
system software. 
 2.3.8 Cell apoptosis analysis 
The cells were detached and washed with a cold cell-staining buffer solution after the treatment. 
Then, the cells were resuspended in 100-µL Annexin V-binding buffer and then transferred to 
EDTA tube. FITC Annexin V (5 µL) and 10 µL of PI was added to the cell suspension, which 
was gently vortexed and incubated for 15 min at room temperature (25°C) in the dark. Annexin 
V-binding buffer (400 µL) was added to the EDTA tube, and the samples were analyzed using 
flow cytometry with the appropriate machine settings. 
 2.3.9 Statistical analyses 
 All the tests were performed in three repetitions. Statistical analyses were performed 
using the SAS Studio version 3.8 (2008) software (SAS University Edition) at 5% probability. 
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 2.4 Results 
 2.4.1 Total phenolic content 
The TPCs of the two sorghum accessions were determined using the Folin-Ciocalteu method. 
The results were expressed as milligram gallic acid equivalent per gram of dry weight 
(mgGAE/g DW) and shown in Table 1. F10000 with a white pericarp has a low TPC of 2.11 mg 
GAE/g DW, while PI329694 with a black pericarp has a high TPC of 21.89 mg GAE/g DW. 
 2.4.2 Cell inhibition 
The cell inhibition of the HepG2 and Caco-2 cells treated with the two sorghum phenolic 
extracts at 0–200 μM GAE for up to 72 h are shown in Figures 1 and 2, respectively. The 
sorghum accessions at various concentrations in both cell lines showed a dose dependent 
manner, with significant differences between concentrations. The higher the sorghum phenolic 
content, the stronger the cell inhibition.  
 2.4.3 Cell apoptosis analysis 
With regard to apoptosis, the results of the cell treatments with sorghum accessions F10000 and 
PI1329694 at 0–200 μM GAE for up to 72 h are shown in Figures 3 and 4. The results showed 
that both sorghum accessions significantly increased the percentage of apoptotic cells as the 
sorghum phenolic extract dose was increased. The flow cytometry results for both cell treatments 
with the representative sorghum phenolic extracts at 200 μM GAE are shown in Figure 5. The 
results for the HepG2 cells showed that the number of apoptotic cells was increased by 9% by 
F10000 with a white pericarp and by 23.1% with PI1329694 with a black pericarp compared 
with the control. A similar trend but with a mild increase was observed in Caco-2. 
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 2.5 Discussion 
The aim of this study was to examine the usefulness of the sorghum accessions of the 
white (F10000) and black pericarps (PI1329694) in the HepG2 and Caco-2 cell lines for cancer 
prevention. These two colors of sorghum accessions were selected on the basis of their phenolic 
contents. Accession F10000 with a white pericarp contained low levels of phenolic compounds, 
whereas accession PI1329694 with a black pericarp contained high levels of phenolic 
compounds. The study used two cell lines, one from liver cancer and the other from colorectal 
cancer. These cell lines were selected because the major site of metabolites and absorption of 
various substances including phenolic compounds. 
In this study, the TPCs of two sorghum accessions were determined using the Folin-
Ciocalteu method. The white-pericarp sorghum accession (F10000) had a low TPC of 2.11 mg 
GAE/g DW, whereas the black-pericarp sorghum accession (PI329694) has a high TPC of 21.89 
mg GAE/g DW. 
After incubation with each treatment, the two cell lines treated with F10000 and 
PI329694 extracts showed the phenolic extracts effectively inhibited HepG2 or Caco-2 cancer 
cell growth in a dose-dependent manner. These results also indicated that sorghum accessions 
rich in phenolic compounds significantly suppressed the cell growth in both HepG2 and Caco-2 
cell. The result demonstrated phenolic extracts from sorghum accessions (F10000 and PI329694) 
can inhibit the cell growth of HepG2 and Caco-2 cells in vitro (Figures 2.1 and 2.2).  
After incubation with each treatment, cells were detached by 0.05% trypsin at 37 °C and 
then suspended in DPBS for further apoptosis analysis. The apoptosis analysis was conducted in 
accordance with the BioLegend FITC Annexin V staining procedure and detected by flow 
cytometer and result in a cell distribution graph. Among the data, the phenolic extracts at 200 
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μM GAE in two sorghum accessions significantly induce the apoptotic cells in HepG2 and Caco-
2 cells. Figure 3 is the overall apoptosis result of sorghum extracts from 0 to 200 μMGAE in 
HepG2 and Caco-2. It shows the phenolic extracts in two sorghum accessions effectively induce 
HepG2 or Caco-2 apoptotic cell in a dose-dependent manner. These results also indicated that 
sorghum accessions rich in phenolic compounds significantly induce apoptosis in both HepG2 
and Caco-2 cell. The result demonstrated phenolic extracts from sorghum accessions (F10000 
and PI329694) can induce cell apoptosis of HepG2 and Caco-2 cells in vitro.  
In conclusion, the study demonstrated that cell inhibition by the sorghum phenolic 
extracts was significantly associated with their phenolic content. The Two sorghum accessions 
selected in this study effectively induced the apoptotic cells in HepG2 and Caco-2 cancer cells 
and was significantly associated with the concentration of the sorghum phenolic extracts. 
Overall, this study suggests that sorghum prevent against cancer through phenolic-mediated 













Table 2-1 Total Phenolic Contents in Sorghum Accessions 





Figure 2.1 Cell inhibition 0-200 µM GAE 
 
The inhibition effect of phenolic extracts from two sorghum ascensions at 0-200 µM GAE in 
HepG2 cells after 72 hrs. Values are expressed as Mean ± SD (n = 3), Means with different 




Figure 2.2 Apoptosis induction at 200 µM GAE with flow cytometer graph 
 
Apoptosis induced by representative sorghum phenolic extracts (200 µM GAE) in HepG2 and 
Caco-2 cell lines. Values are expressed as Mean ± SD (n = 3), Means with different alphabetical 
letters differ significantly, p ≤ 0.05 
 
Figure 2.3 Overall apoptosis induction at 0-200 µM GAE 
 
Apoptosis induced by sorghum phenolic extracts from 0-200 µM GAE in HepG2 and Caco-2. 
Values are expressed as Mean ± SD (n = 3), Means with different alphabetical letters differ 
significantly, p ≤ 0.05 
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